Test results
| Appearance | Good · Pass |
|---|---|
| Identity | Confirmed · HPLC · Pass |
| Purity | 99.64% · HPLC · Spec ≥ 95.0% · Pass |
| Net peptide content | 1039.44 mg · HPLC · Report only |
| Sterility | No Growth · PCR · Pass |
| Endotoxins | <0.05 EU/mL · LAL · Spec ≤ 5 EU/mL · Pass |
| Heavy metals | All Below Limits · ICP-MS · USP <233> · Pass |
| Fentanyl screen | Not detected · Pass |
Batch details
| Product | NAD+ (Nicotinamide Adenine Dinucleotide) |
|---|---|
| Batch / lot | NAD002 |
| Certificate number | COA-2026-412889 |
| Laboratory | ILS Laboratories (ISO/IEC 17025 accredited) |
| Tested | Jun 10, 2026 |
| Labeled amount | 1000mg |
| Method | Full QC Panel |
| Lab verdict | PASS |
Original certificate
Open the image for the full-size report. Match the lot number printed on your vial to NAD002. Every other batch of NAD+ (Nicotinamide Adenine Dinucleotide) is listed on its product page.
New to certificates of analysis? What is a COA? explains the tests on this page and how labs check identity and purity.
Other batches of NAD+ (Nicotinamide Adenine Dinucleotide)
- Batch NAD005, tested Jul 7, 2026
- Batch 543D, tested May 26, 2026
- Batch #35471, tested May 24, 2026
- Batch #35473, tested May 24, 2026
- Batch 55F, tested Apr 3, 2026
- Batch 5159513N, tested Dec 24, 2025